6th Dec 2018 14:19
LONDON (Alliance News) - Novacyt SA on Thursday said it has secured a substantial order for Primerdesign's genesig q16 instruments from a new customer within the Chinese market.
Primerdesign is a biotechnology company, which became part of Novacyt in May 2016. The genesig q16 is Primerdesign's proprietary molecular testing instrument which is designed to make DNA testing affordable and easy to use.
The clinical diagnostics company said the order for 100 molecular diagnostic instruments has been paid in advance. The order takes the number of q16 instruments sold into the Asia Pacific region to over 230 units.
This new contract provides Novacyt with a potential opportunity for further significant instrument, and genesig reagent sales in 2019, it said. In the year-to-date, Novacyt said genesig reagent sales have increased 35% year-on-year.
"I am very pleased to see this order from another new customer in China which helps to further reinforce our continued investment and success in the Asia Pacific region and provides additional opportunities for future instrument and reagent sales," said Chief Executive Graham Mullis.
Novacyt shares were untraded on Thursday, last closing at 34.00 pence each.
Related Shares:
Novacyt